Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
December 19, 2024 08:00 ET
|
Quoin Pharmaceuticals, Inc.
Groundbreaking ‘Whole Body’ Study will be conducted by Dr. Amy Paller at Northwestern University Up to eight subjects will have QRX003 applied twice daily to greater than 80% of their body surface...
Macular Edema Global Clinical Trials Review 2024 - Coverage of Disease Clinical Trials by Region, Country, Phase, Trial Status, End Points Status and Sponsor Type
December 19, 2024 04:33 ET
|
Research and Markets
Dublin, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The "Macular Edema - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
December 18, 2024 08:18 ET
|
Quoin Pharmaceuticals, Inc.
Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only...
Targeted Alpha Therapy Market, Drugs Approval, Proprietary Technologies & Clinical Trials: 20+ Drugs of Targeted Alpha Therapy In Clinical Trials
December 16, 2024 10:53 ET
|
Research and Markets
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ...
Pharming announces positive topline data in pediatric clinical trial of leniolisib
December 11, 2024 01:00 ET
|
Pharming Group N.V.
Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Data consistent with the improvements seen in the previously...
H1 Partners with CTI to Streamline Clinical Trial PI and Site Selection for More Inclusive and Efficient Trials
December 10, 2024 09:00 ET
|
H1
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- H1, on a mission to connect the world to the right doctors, today announced a strategic partnership with CTI Clinical Trial & Consulting Services...
CD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase
December 09, 2024 04:48 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
December 09, 2024 02:00 ET
|
Bionical Emas
Bionical Emas, the Early Access Programs and Clinical Trial Supply business, is selling EMAS Pharma to Kester Capital and an incoming executive team.
Clinical Trial Supplies Industry Forecast Report 2025-2033: $4.79 Billion Market Soars as Chronic Disease Incidence Rises Globally
December 05, 2024 04:31 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Global Forecast Report by Services, Phase, Therapeutic Area, End Use, Countries and Company Analysis 2025-2033" report...
Adaptive Research Welcomes Western Radiation Oncology to Expand Community Access to Pioneering Cancer Treatment Trials
December 04, 2024 08:00 ET
|
Adaptive Research Inc
Western Radiation Oncology has joined Adaptive Research’s growing network of community physician practices.